Carpenter Technology CRS Medical — Total Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Carpenter Technology in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Carpenter Technology’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Carpenter Technology's medical — total net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Carpenter Technology's medical — total net sales?
- Carpenter Technology (CRS) reported medical — total net sales of $65.8M in Q1 2026.
- How has Carpenter Technology's medical — total net sales changed year-over-year?
- Carpenter Technology's medical — total net sales decreased by 22.6% year-over-year, from $85M to $65.8M.
- What is the long-term trend for Carpenter Technology's medical — total net sales?
- Over 3 years (2022 to 2025), Carpenter Technology's medical — total net sales has grown at a 18.3% compound annual growth rate (CAGR), from $212.3M to $351.3M.
- What does medical — total net sales mean?
- This metric represents the total revenue generated from the sale of specialty alloy products and engineered materials specifically tailored for the medical device and healthcare industry. It reflects the company's market penetration and demand within the medical sector, which often requires high-precision, biocompatible, and regulatory-compliant materials. Tracking this figure helps investors assess the company's growth trajectory and competitive positioning in high-value, specialized end markets.